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Precis 
In this longitudinal 28-year follow-up study including 1422 individuals, parental smoking and elevated 
cotinine levels in childhood were associated with lower bone mineral density in adulthood.  
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Abstract 
Context: Passive smoke exposure has been linked with the risk of osteoporosis in adults. 
Objective: We aimed to examine the independent effects of exposure to passive smoking in childhood on adult 
bone health.  
Design/Setting: Longitudinal, the Cardiovascular Risk in Young Finns Study 
Participants: Study cohort included 1422 individuals followed up for 28 years since baseline in 1980 (age 3-
18 years). Exposure to passive smoking was determined in childhood. In adulthood, peripheral bone traits were 
assessed with quantitative computed tomography (pQCT) at the tibia and radius, and calcaneal mineral density 
was estimated with quantitative ultrasound. Fracture data was gathered by questionnaires. 
Results: Parental smoking in childhood was associated with lower pQCT derived bone sum index in adulthood 
(β±SE -0.064±0.023 per smoking parent, P=0.004) in multivariate models adjusted for age, sex, active 
smoking, BMI, serum 25-OH vitamin D concentration, physical activity, and parental socioeconomic position. 
Similarly, parental smoking was associated with lower heel ultrasound estimated bone mineral density in 
adulthood (β±SE -0.097±0.041 per smoking parent, P=0.02). Parental smoking was also associated with the 
incidence of low-energy fractures (odds ratio 1.28, 95% confidence interval 1.01-1.62). Individuals with 
elevated cotinine levels (3-20 ng/ml) in childhood had lower bone sum index with pQCT (β±SE -0.206±0.057, 
P=0.0003). Children whose parents smoked and had high cotinine levels (3-20 ng/ml) had significantly lower 
pQCT derived bone sum index compared to those with smoking parents but low cotinine levels (<3ng/ml) 
(β±SE -0.192±0.072, P=0.008). 
Conclusions and relevance: Children of parents who smoke have evidence of impaired bone health in 
adulthood.  
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Introduction 
Osteoporosis is a chronic systemic skeletal disease associated with elevated bone fracture risk due to a 
reduction in bone mass and alterations in bone quality. It is becoming an increasing public health concern 
along with aging populations1. Osteoporosis annually contributes to approximately 10 million fractures2. 
Although these fractures mostly occur in elderly people, the risk of osteoporosis may be influenced by early 
life exposures effecting the growing bone3. Therefore, it is important to identify the determinants of bone 
health. In prior studies, childhood growth/adiposity, physical activity and socioeconomic position have been 
related with bone quantity and quality4-6. 
 
An important environmental factor linked with osteoporosis in adults is exposure to tobacco smoke. The effects 
of smoking are cumulative over time, with an additional bone loss (independent of body weight and physical 
activity) of 4% by age 70, 6% by age 80, and 8% by age 90 years7. Meta-analyses have reported an increased 
fracture risk related to smoking in both men and women7-9. Importantly, exposure to secondhand smoke, i.e. 
passive smoking, 10-12 has also been associated with osteoporosis. However, little is known of the bone health 
effects of childhood exposure to passive smoking. One retrospective study in premenopausal women suggested 
a link between self-reported passive smoking in adolescence and reduced bone mass in adulthood12.  
 
In the present study, we aimed to examine passive smoking exposure in childhood (age 3-18 years) as a 
determinant of bone health at the skeletal maturity in mid-adulthood (age 31-46 years) among 1422 individuals. 
The analyses were performed in the longitudinal Cardiovascular Risk in Young Finns Study with data on 
peripheral bone traits of radius, tibia and calcaneus assessed with quantitative computed tomography13 and 
heel ultrasonography14, and questionnaire based information on low-energy fractures.   
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Materials and methods 
Description of the Cardiovascular Risk in Young Finns Study has been published previously15. The study was 
approved by the institutional ethics committees, and written informed consent was obtained from all the study 
participants or their parents. Present analysis included 1422 participants who had a baseline evaluation during 
childhood in 1980 and a follow-up bone health examination 28 years later in adulthood. To control for active 
smoking in childhood and adolescence, the analyses were conducted after excluding the participants who were 
active smokers during the baseline evaluation. Detailed methods are provided in the Supplementary 
Appendix16. 
Childhood exposure measures – parental smoking and serum cotinine 
Parents of participants self-reported their smoking habits at baseline17. One parent responding on behalf of 
both parents was asked to indicate the smoking status separately of the mother and father in the household 
from two questions. The first question was whether mother/father had ever smoked daily for at least one year 
(responses “Yes” or “No”), and the second question whether mother/father were currently smoking (responses 
“does not smoke”, “occasionally”, “daily”). Mothers or fathers indicating they had ever smoked daily for at 
least one year were designated as ever smokers. Mothers or fathers that indicated currently occasionally or 
daily smoking were designated as current smokers.  
Serum samples were collected in 1980 and stored at -20°C until they were analyzed in 2014. During storage, 
samples were not thawed or refrozen. Serum cotinine measures were performed using standardized methods18. 
Cotinine values between 3-20 ng/ml in non-smokers were considered as indicative of positive nicotine 
exposure indicative of passive smoking (the concentration that could be detected reproducibly in the assay). 
A three-level variable to indicate parental smoking hygiene was constructed as follows: 1 = no parental 
smoking and non-detectable cotinine level; 2 = parental smoking and non-detectable cotinine level (hygienic 
parental smoking); and 3 = parental smoking and detectable serum cotinine (non-hygienic parental smoking). 
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Adult outcome variables - bone traits 
Peripheral quantitative computed tomography (pQCT) (Stratec XCT 2000R, Germany) was used to scan two 
sites (distal and diaphysis) of radius and tibia19. This method provides data on volumetric bone mineral density 
(vBMD). The following bone traits were measured: total bone mineral content (mass), total and cortical bone 
areas, and trabecular and cortical bone densities. In addition, three bone strength indices were estimated. From 
these data, four composite indices of bone mass, density, area and strength were calculated. Additionally, the 
four indices were combined into one age- and sex-standardized bone sum index. In attrition analyses 
comparing baseline characteristics between those attending (N=1800) and those non-attending (N=1796) the 
bone study, it was observed that non-attendants were younger (10.0 vs 10.9 years, P<0.001) and more often 
males (55 vs 43%, P<0.0001). However, there were no differences in baseline BMI (17.8 vs. 17.9 kg/m2, 
P=0.20) or parental school years (10.7 vs 10.7 years, P=0.97). As another variable, we measured heel bone 
traits with a quantitative ultrasound device (Sahara Clinical Bone Sonometer, Hologic, Waltham, MA, USA) 
among 1210 participants. It measures the speed of sound and ultrasound attenuation at the mid-calcaneus as 
the sound waves traverse through bone tissue. The speed of sound (m/s) is linearly dependent on bone mineral 
density20. Additionally, an estimate of heel bone mineral density Z-score was calculated as the difference from 
the age- and sex-specific averages. Persons performing bone measurements were blinded to the parental 
smoking status. Detailed description of measurement and calculation of bone traits is given in the 
Supplementary appendix16. 
Fractures 
During the bone study visit, participants were inquired their fracture history. Questionnaire information on 
fracture site, fracture age, and how the fracture occurred were collected. Fractures were classified as low-
energy fractures if they were sustained in standing positions, and in the absence of excess strain due to falling 
from heights greater than standing level or due to the high speed of a vehicle used (cycling, skiing, skating), 
or if no other person or external factor was involved.   
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Covariates 
To control for the effect of body size, we utilized serial data on height and weight collected in clinical 
examinations in 1980, 1983 and 1986 to calculate the estimated area under the body mass index curve between 
ages 6 and 24 years21. Data collected in study years 1980, 1983 and 1986 were used to estimate physical activity 
in childhood, adolescence and young adulthood. At ages 3 and 6 years, a preschool children physical activity 
index was calculated from the parents’ ratings of the amount and vigorousness of their child’s play time and 
the child’s general level of activity as compared with other children22. At ages 9-24 years data on frequency 
and intensity of physical activity during leisure time were acquired with a self-administered questionnaire and 
a sum index of physical activity was calculated23. The values for physical activity indices were standardized 
and the average value was used as a measure of physical activity exposure during the time of peak bone mass 
accrual. As a marker of nutritional vitamin D status, the baseline (year 1980) circulating 25-OH vitamin D 
concentration was measured using radioimmunoassay (DiaSorin, Stillwater, MN). In adulthood, information 
on smoking was collected with questionnaires in 2001 and 2007. Data on parental education (years) was used 
as an indicator of the childhood socioeconomic status. Information on birth weight was collected using 
questionnaires and confirmed from participants’ records from well-baby clinics.  
Statistical analysis 
Statistical analysis was performed using SAS 9.3. Statistical significance was inferred by a P value <0.05. 
Parental smoking, serum cotinine, and parental smoking hygiene were used as exposure variables in 
multivariable linear regression models to examine effects of childhood passive smoking on pQCT and 
ultrasound derived bone indices. Analyses using dichotomized fracture data as an outcome were performed 
with logistic regression analyses. Stepwise multivariate regression with backward elimination was performed 
to take into account the effects of possible intermediate or confounding factors. Variables in initial stepwise 
multivariate models included age, sex, body mass index, physical activity, parental school years, and serum 
25-OH vitamin D in childhood. Age and sex were forced into the final models. In addition, the effects of birth 
weight and smoking in adulthood were controlled for in additional models.  
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We examined potential sex and age interactions by including interaction terms in logistic regression models. 
In addition, we investigated differences between the effects of a smoking mother and a smoking father. 
Replications of the analyses were done including only life-long non-smokers. Sensitivity analyses were 
performed using different cut-offs for serum cotinine (2.5, 3.0, 3.5 or 4.0 ng/L) to indicate passive smoking.  
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Results 
Baseline characteristics (in 1980) stratified by parental smoking exposure are shown in Supplementary Table 
116. Bone measures, the calculation of bone indices and their mean values are shown in Supplementary Table 
216. 
Parental smoking and bone health 
The effect of regular parental smoking during childhood on the pQCT derived bone indices in adulthood is 
shown in Table 1. In multivariable models, exposure to parental smoking was statistically significantly and 
inversely associated with the bone sum index, bone mass, bone density and bone strain, but not with bone area. 
The effect estimates of parental smoking remained essentially similar when the analyses were adjusted for 
birth weight (N=1214) or active smoking in adulthood (N=1345), or when active smokers in adulthood were 
excluded (N=1135). No evidence of statistically significant sex interactions was observed. Similarly, no 
significant age interactions were detected. The effect estimates were nearly identical for paternal smoking and 
maternal smoking.  
Results for ultrasound measured bone indices are in Table 2. Parental smoking was inversely related with 
broadband attenuation, speed of sound and estimated bone mineral density Z-score. The findings remained 
essentially similar when additionally adjusted for birth weight (N=1067) or active smoking in adulthood 
(N=1171), or when active smokers in adulthood were excluded (N=961). There were no age-interactions, but 
statistically significant sex interactions were observed for all indices. In sex-stratified analyses, parental 
smoking was related with ultrasound derived bone indices among females (P always < 0.005), but not in males 
(P always > 0.6). The effect estimates were comparable for paternal and maternal smoking.  
Questionnaire based low-energy fracture rates among individuals with 0, 1 and 2 smoking parents were 9.2, 
12.0 and 13.7 %, respectively. Odds ratio per smoking parent was 1.28 (95% CI 1.01-1.62, P=0.04) in a logistic 
regression model adjusted for age, sex and childhood factors. The results remained essentially similar when 
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the analyses were additionally adjusted for birth weight or active smoking in adulthood, but the association 
was attenuated when active smokers in adulthood were excluded (P=0.24). 
Cotinine exposure in childhood and bone health 
Passive smoking in childhood, defined as a serum cotinine concentration between 3-20 ng/ml, was inversely 
associated with the pQCT derived bone sum index and the bone mass, density and strength indices in adulthood 
(Table 3). These associations remained similar after additional adjustment for birth weight (N=1047) or 
smoking in adulthood (N=1195), or when active smokers in adulthood were excluded (N=995). There were no 
significant age or sex interactions.  
Concerning ultrasound measures, cotinine exposure was inversely associated with speed of sound (Table 4). 
Effect estimates were not altered after additional adjustments for birth weight (N=887) or active smoking in 
adulthood (N=1006), or when active smokers in adulthood were excluded (N=835). No significant age or sex 
interactions were observed. 
Those individuals with low cotinine levels had a low-energy fracture rate of 11.3 % and among those with 
elevated cotinine it was 14.3% (P=0.15 in a logistic regression model adjusted for age, sex and childhood 
factors). 
Parental smoking hygiene in childhood and bone health in adulthood 
Figure 1 shows the association between parental smoking hygiene and bone indices. Children whose parents 
smoked non-hygienically (cotinine levels in children 3-20 ng/ml) had lower pQCT derived bone sum index 
compared with those whose parents smoked hygienically (cotinine levels in children <3ng/ml) or those whose 
parents did not smoke (Figure 1). Concerning ultrasound derived estimated bone mineral density Z-score, there 
were no differences between the groups (Figure 2).  
12 
Sensitivity analyses and replication 
In analyses restricted to life-long non-smokers results were essentially similar to those shown in Tables 1-4. 
There were no significant differences in the effects of passive smoking in childhood on bone traits according 
to different cotinine concentration cut-offs (Supplementary Table 316). Results remained similar when no upper 
limit to cotinine concentrations was applied. 
13 
Discussion 
We observed that exposure to passive smoking in childhood, determined by parental smoking and serum 
cotinine concentrations, was a significant determinant of reduced bone mass, density and strength indices 
measured 28 years later in adulthood with two different methods. The effect of passive smoking in childhood 
was not attenuated after adjustments for age and sex and the possible intermediate or confounding factors, 
including BMI, active smoking, serum 25-OH vitamin D concentration, physical activity, parental school years 
and birth weight. 
In adulthood, active smoking is a risk factor for osteoporosis and bone fractures7,8,24-28. Less is known of the 
effects of passive smoking on bone health. In adults, passive smoking has been inversely associated with 
phalangeal bone mineral density in a cohort of 15,038 adults aged 19-95 years10. Similar results were found in 
2067 postmenopausal women, where passive smoking confirmed by urinary cotinine analysis was directly 
associated with osteoporosis11. Even less is known of passive smoking in childhood. In a retrospective study 
on 154 premenopausal women, self-reported exposure to passive smoking from age 10 onwards was negatively 
associated with total hip and femoral neck bone mineral density when aged 40-45 years12. The results of the 
present prospective study indicate that parental smoking exposure in childhood affects subsequent bone quality 
traits measured in mid-adulthood. 
Concerning other childhood risk factors, the available prospective longitudinal studies demonstrating links 
between childhood exposures and adult bone health outcomes have mainly evaluated the effects of early 
growth, physical activity and socioeconomic position. It has been shown that poor fetal and infant growth and 
low levels of physical activity in childhood are associated with reduced peak bone mass later in life29. Direct 
relations have been observed between childhood overweight and adult bone density, supporting the hypothesis 
that excess weight during active growth imposes increased loading on the weight-bearing skeleton and leads 
to more robust bones in adulthood19. Among white males, socioeconomic disadvantage in childhood has been 
associated with lower adult femoral neck strength6. In the present analyses, the effects of childhood exposure 
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to secondhand smoke on bone health were independent of these factors, as well as other possible confounders, 
such as vitamin D concentrations and family socioeconomic status.  
 
Most plausible mechanisms in smoking-induced bone loss may be increased bone resorption and a less efficient 
calcium absorption30 and effects on circulating levels of sex hormones and 25-OH vitamin D25. Experimental 
nicotine exposure inhibited matrix synthesis and hypertrophic differentiation in human growth plate 
chondrocytes31. There is a large body of evidence from experimental studies that tobacco smoke has adverse 
effects on osteoneogenesis and osseointegration in bone cell culture and animal models via several 
mechanisms32. In animal models of bone biomechanical properties, tobacco smoke exposure decreased the 
structural strength, material properties, bone mass, and trabecular quality in the growing female mouse33, and 
decreased bone mineral density through increased bone turnover in the female rat34. Nicotine has been 
suggested to have a direct toxic effect on osteoblasts35. However, experimental nicotine administration in rats 
caused no differences in bone mineral content or other bone traits between the low and high nicotine doses36,37. 
Thus, substances in smoke other than nicotine may also be responsible for the decreased bone density. In the 
present study, independent associations were seen with different indices of bone mineral density, bone mass 
and strength after a 28-year follow-up in both men and women, suggesting that tobacco smoke exposure may 
compromise the growing bone through multiple mechanisms. 
 
From a clinical point of view, we observed in multivariable models that parental smoking in childhood was 
associated with up to 0.19 SD worse (estimated heel BMD, for both parents smoking) bone measures, and 
elevated cotinine levels (3-20 ng/L) were related with over 0.2 SD lower bone sum index. In addition, parental 
smoking was related with low-energy fractures. In prospective observational data, 1-SD decrease in bone 
mineral density with DXA has been related to approximately 1.4 times elevated total osteoporotic fracture risk 
at the age of 65 years38. However, for hip fractures the respective risk ratio for 1 SD change in bone mineral 
density is 2.9 at the age of 65 years and the relative risk significantly increases with decreasing age38. For these 
reasons, it would be essential to have increased public health awareness to the harms associated with 
secondhand tobacco smoke, especially in childhood. There would be several different ways to limit children’s 
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exposure to environmental tobacco smoke, including restrictions to smoking in public places, in vehicles, and 
at home. Smoking restrictions in public and work places have been shown to decrease hospitalizations for 
cardiovascular and respiratory disease among adults39. However, there are observational data suggesting that 
public smoking regulations may have increased passive smoke exposure in private places, such as at home40. 
Therefore it would be important to communicate to parents that their smoking has effects on their children’s 
health, both in short and long term.  
 
Our study has limitations. There was only a single measurement of parental smoking and of serum cotinine 
concentration in childhood at the age of 3 to 18 years. However, we did not detect age interactions, indicating 
that a single measurement in childhood may be representative of exposure from childhood through youth. We 
were unable to determine an age when exposure to parental smoking may have been most detrimental to bone 
health. A limitation may also be that no data were available on smoking during pregnancy which may affect 
birth weight, however all models were adjusted for birth weight. The present pQCT and ultrasound results 
performed in peripheral bones, including calculations of bone sum index, provide epidemiological data and 
they do not have instant clinical utility. The estimated BMDs and Z-scores are not comparable with DXA 
measurements and they cannot be used for diagnostic classification. Another potential limitation is the non-
participation in the bone measurement study. However, even though non-participants were younger and more 
often males, their baseline characteristics (BMI, parental education) were similar. Thus the present study cohort 
seems to be representative of the original study population. The strengths of our study are the large, well 
characterized population with a long clinical follow-up and the bone measurement methods of assessing 
peripheral bone mass, density, area and strength from three different bones, radius, tibia and calcaneus. A 
further strength is that exposure to secondhand smoke in childhood could be confirmed by serum cotinine 
which is a biomarker of nicotine exposure. Furthermore, we performed the analyses excluding those who had 
reported own smoking at the baseline. 
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Our results suggest that bone traits are persistently affected by exposure to passive smoking in childhood, 
independent of potential confounding factors. Programs aimed at avoiding exposure to tobacco smoke early in 
life could improve later bone health of children in risk to passive smoke exposure. 
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Figure legends 
 
Figure 1.  
Effect of parental smoking hygiene at the offspring’s age of 3-18 years on bone sum index measured with 
peripheral quantitative computed tomography in adulthood (age 31-46 years). Results are expressed as 
mean±SEM, p-values are from regression analyses adjusted for age, sex, childhood body mass index, 
physical activity, parental school year and 25-OH vitamin D-concentration. Serum cotinine concentration 
between 3 and 20 ng/ml was considered elevated.   
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Figure 2. 
Effect of parental smoking hygiene at the offspring’s age of 3-18 years on calcaneal bone mineral density Z-
score estimated with ultrasound in adulthood (age 31-46 years). Results are expressed as mean±SEM, p-
values are from regression analyses adjusted for age, sex, childhood body mass index, physical activity, 
parental school year and 25-OH vitamin D-concentration. Serum cotinine concentration between 3 and 20 
ng/ml was considered elevated. 
22 
 
Table 1. Multivariable regression results of the independent effects of parental smoking in childhood (age of 3-18 years) on bone quality indices measured by peripheral 
quantitative computed tomography in adulthood (age 31-46 years) from 1422 participants (aged 31-46 years) of the Cardiovascular Risk in Young Finns Study. 
 
Bone sum index (z-score) 
 
Bone mass (mg) 
 
Bone density (mg/cm3) 
 
Bone area (mm2) 
 
Bone strain (z-score) 
 
 β±SE P β±SE P β±SE P β±SE P β±SE P 
Age (years) 0.016±0.003 <0.0001 5.8±1.0 <0.0001 -0.13±0.09 0.17 6.7±1.1 <0.0001 0.015±0.003 <0.0001 
Male sex 1.509±0.033 <0.0001 511.2±9.4 <0.0001 4.76±0.91 <0.0001 408.5±10.4 <0.0001 1.614±0.029 <0.0001 
Childhood body mass index 0.237±0.017 <0.0001 85.8±5.0 <0.0001   72.1±5.5 <0.0001 0.244±0.016 <0.0001 
Childhood physical activity 0.129±0.019 <0.0001 47.4±5.4 <0.0001   35.1±6.0 <0.0001 0.110±0.017 <0.0001 
Parental smoking * -0.064±0.023 0.004 -17.1±6.4 0.008 -1.27±0.63 0.04 -11.1±7.4 0.12 -0.042±0.020 0.04 
 
Results are from stepwise multivariable models. β = Parameter estimate for change in the outcome variable for 1-standard deviation / 1-category change in the exposure. 
SE = standard error. Initial models included data on age, sex, childhood body mass index, physical activity, parental school years, 25-OH vitamin D-concentration and 
parental smoking. Age and sex were forced into final models. * Effect per one smoking parent.  
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Table 2. Multivariable regression results of the independent effects of parental smoking in childhood (age of 3-18 years) on ultrasound derived bone quality indices 
in adulthood (age 31-46 years) from 1210 participants (aged 31-46 years) of the Cardiovascular Risk in Young Finns Study.  
Broadband  Speed of sound Estimated bone mineral density 
attenuation 
 (dB/MHz) (m/s) (Z-score) 
β±SE P β±SE P β±SE P 
Age (years) 0.3±0.1 0.01 0.1±0.2 0.85 0.011±0.006 0.09 
Male sex 2.3±1.0 0.02 -0.7±1.7 0.70 -0.075±0.060 0.21 
Childhood body mass index 2.5±0.5 <0.0001 2.6±0.9 0.005 0.123±0.032 0.0001 
Childhood physical activity 1.8±0.6 0.001 3.7±1.0 0.002 0.116±0.034 0.0009 
Parental smoking * -1.6±0.6 0.02 -2.7±1.1 0.02 -0.097±0.041 0.02 
Results are from stepwise multivariable models. β = Parameter estimate for change in the outcome variable for 1-standard deviation / 1-category change in the exposure. 
SE = standard error. Initial models included data on age, sex, childhood body mass index, physical activity, parental school years, 25-OH vitamin D-concentration and 
parental smoking. Age and sex were forced into final models. * Effect per one smoking parent. 
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Table 3. Multivariable regression results of the independent effects childhood exposure to cotinine (age of 3-18 years) on bone quality indices measured by peripheral 
quantitative computed tomography in adulthood (age 31-46 years) in 1201 participants (aged 31-46 years) of the Cardiovascular Risk in Young Finns Study.  
 
Bone sum index (z-score) 
 
Bone mass (mg) 
 
Bone density (mg/cm3) 
 
Bone area (mm2) 
 
Bone strain (z-score) 
 
 β±SE P β±SE P β±SE P β±SE P β±SE P 
Age (years) 0.014±0.004 0.0003 5.4±1.1 <0.0001 -0.2±0.1 0.09 6.6±1.2 0.002 0.014±0.004 0.0002 
Male sex 1.502±0.036 <0.0001 509.7±10.1 <0.0001 4.6±1.0 <0.0001 405.9±11.1 <0.0001 1.614±0.031 <0.0001 
Childhood body mass index 0.215±0.019 <0.0001 79.4±5.4 <0.0001   73.2±5.9 <0.0001 0.226±0.017 <0.0001 
Childhood physical activity 0.146±0.022 <0.0001 55.2±6.2 <0.0001   34.0±6.8 <0.0001 0.132±0.019 <0.0001 
Elevated cotinine in 
childhood * 
-0.206±0.057 0.0003 -47.6±16.0 0.003 -6.1±1.6 0.0001 -4.1±17.6 0.81 -0.149±0.050 0.003 
Results are from stepwise multivariable models. β = Parameter estimate for change in the outcome variable for 1-standard deviation / 1-category change in the exposure. 
SE = standard error. Initial models included data on age, sex, childhood body mass index, physical activity, parental school years, 25-OH vitamin D-concentration and 
parental smoking. Age and sex were forced into final models. *Serum cotinine concentration between 3 and 20 ng/ml 
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Table 4. Multivariable regression results of the independent effects childhood exposure to cotinine (age of 3-18 years) on ultrasound derived bone quality indices in 
adulthood (age 31-46 years) in 1011 participants (aged 31-46 years) of the Cardiovascular Risk in Young Finns Study. 
Broadband  Speed of sound Estimated bone mineral density 
attenuation 
 (dB/MHz) (m/s) (Z-score) 
β±SE P β±SE P β±SE P 
Age (years) 0.4±0.1 0.001 0.2±0.2 0.34 0.016±0.007 0.02 
Male sex 2.0±1.0 0.05 -1.2±1.9 0.53 -0.079±0.065 0.22 
Childhood body mass index 2.3±0.5 <0.0001 2.4±1.0 0.02 0.115±0.035 0.001 
Childhood physical activity 3.0±0.6 <0.0001 5.8±1.2 <0.0001 0.187±0.041 <0.0001 
Elevated cotinine in childhood * -2.2±1.6 0.16 -7.0±2.9 0.01 -0.184±0.099 0.06 
Results are from stepwise multivariable models. β = Parameter estimate for change in the outcome variable for 1-standard deviation / 1-category change in the exposure. 
SE = standard error. Initial models included data on age, sex, childhood body mass index, physical activity, parental school years, 25-OH vitamin D-concentration and 
parental smoking. Age and sex were forced into final models. *Serum cotinine concentration between 3 and 20 ng/ml 
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Supplementary Appendix 
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Supplementary methods 
Study population 
The Cardiovascular Risk in Young Finns Study is a population-based cohort study on cardio-
metabolic risk factors from childhood through adulthood. At baseline in 1980, 3,596 children and 
adolescents aged 3, 6, 9, 12, 15 and 18 years (83% of those invited) were examined at five study 
centers in Finland. Follow-up studies have been conducted in 1983, 1986, 2001, 2007, and 2011. In 
2008, all original study participants now aged 31 to 46 years, alive and living in Finland (N = 3,386) 
were invited to peripheral quantitative computed tomography and heel ultrasound measurements 
that were organized in five study centers (cities of Turku, Helsinki, Tampere, Oulu and Kuopio) 
between February and December 2008. Peripheral quantitative computed tomography (pQCT) 
measurements were performed for 1,884 individuals and ultrasound measurements for 1,415 
individuals. Pregnant women were excluded from the computed tomography studies. Complete data 
for the calculation composite indices of quantitative computed tomography measurements of bone 
mass, bone density, bone area and bone strength, and a combined sum index was available for 
N=1,800 participants. The primary statistical analyses included all individuals, who were non-
smokers at baseline, and had data on bone traits, estimated area under the body mass index curve 
between ages 6 and 24 years, parental smoking, serum cotinine, parental education (school years), 
physical activity and serum vitamin D concentration. The number of individuals with complete data 
when assessing the effects of parental smoking on pQCT measures was 1422, and 1201 when 
assessing the effects of serum cotinine. For the ultrasound measures the respective numbers are 
1210 and 1011. 
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Childhood exposure measures – parental smoking, serum cotinine and smoking hygiene 
Parental smoking: Parents of participants self-reported their smoking habits at baseline. One parent 
responding on behalf of both parents was asked to indicate the smoking status separately of the 
mother and father in the household from two questions. The first question asked whether 
mother/father had ever smoked daily for at least one year (responses could be “Yes” or “No”), and 
the second question asked whether mother/father were currently smoking (responses could be “does 
not smoke”, “occasionally”, “daily”). Mothers or fathers that indicated they had ever smoked daily 
for at least one year were designated as ever smokers. Mothers or fathers that indicated they 
currently occasionally or daily smoked were designated as current smokers.  
Serum cotinine: Child fasting serum samples were collected in 1980 and stored at -20°C until they 
were analyzed in 2014. During storage, samples were not thawed or refrozen. The assays were 
performed without knowing the smoking habits of the child or parents. Cotinine was extracted into 
dichloroethane from 0.2 ml of serum to which 0.2 ml of 5-methylcotinine (0.1 µg/ml in 0.01M HCl) 
was added by the method of Feyerabend and Russell1. Concentrated extract (2.0 µl) was injected 
into the Hewlett Packard FFAP silica capillary column (13 m, i.d. 0.32 mm, film thickness 0.52 
µm) of the Shimadzu model GC-17 gas chromatograph, equipped with a nitrogen-sensitive 
Shimadzu FTD-17 flame-thermoionic detector and a Shimadzu AOC-20 auto-injector. The injector 
and detector temperatures were 220°C and 300°C, respectively. The retention times for nicotine, 
cotinine and 5-methylcotinine were 2.9 min, 10.8 min and 12.8 min, respectively. The peak areas 
were analyzed using Shimadzu Class-VP™ chromatography software. 
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The analytical sensitivity of the assay was determined from serum samples with known cotinine 
concentrations. The inter-assay coefficient of variation was 13.3% at a cotinine concentration of 
1.56 ng/ml, 7.2% at a concentration of 3.125 ng/ml, 6.9% at a concentration of 6.25 ng/ml, 3.1% at 
a concentration of 12.5 ng/ml, 1.6% at a concentration of 25 ng/ml, 3.2% at a concentration of 50 
ng/ml, and 1.56% at concentration of 100 ng/ml (6 samples at each concentration). Cotinine 
recovery from serum was 71–150% depending on its concentration. The estimated detection limit 
(mean of a blank sample + 3 standard deviations) was 1.7 + (3×0.4) = 2.9 ng/ml. Values greater than 
3.0 ng/ml were primarily used as an indicator of nicotine exposure.  
Active smoking. The information on smoking habits was collected in 12- to 18-year-olds in 
connection with the medical examination in an isolated room where the participants could respond 
confidentially and undisturbed. The effect of active smoking in adolescence was primarily 
controlled by excluding smokers from the analyses, and secondarily by including adolescent 
smoking as covariate in multivariable models. 
In adulthood, information on smoking was collected with questionnaires in 2001 and 2007. 
To replicate the know effect of active smoking exposure on bone health, we classified individuals 
who had reported ever being active smokers for a period of at least 5 years as exposed (regular 
smoking on daily bases for at least 5 years). 
Parental smoking hygiene: A variable to indicate parental smoking hygiene was generated for those 
participants with both serum cotinine and parental reports of current or ever smoking in 1980. A 
three-level categorical variable was constructed: 1 = no parental smoking; 2 = children with a non-
detectable (values between 0 and 3 ng /ml) cotinine level but whose parents smoked (hygienic 
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parental smoking); and 3 = children with a detectable serum cotinine level 3-20 ng/ml and whose 
parents smoked (non-hygienic parental smoking).  
 
Measurements of the bone traits with computed tomography 
Two sites (distal and diaphysis) of non-weight-bearing radius and weight-bearing tibia were 
measured with computed tomography device (XCT 2000R, Stratec Medizintechnik GmbH, 
Pforzheim, Germany). The distal sites of radius and tibia were scanned at 4% and 5% from the 
distal endplate, respectively. The proximal (shaft) sites of radius and tibia were scanned at 30% 
from the distal endplate. The length of ulna and tibia were measured with a tape measure from the 
proximal end to the distal end. The thickness of the tomographic slice was 2 mm, and the pixel size 
was 0.5×0.5 mm2 in all scans. The scan speed for the scout view was 40 mm/s and for the 
tomographic scan, 20 mm/s. Radius was measured on the non-writing side and tibia on the left side, 
except for those who had metal implants or previous injuries in the non-writing arm or left leg; they 
were measured from the opposite side. During the scanning, the subjects were asked to stay still. In 
case of movement artefacts, the scan was repeated. For the analysis of computed tomography scans, 
outer threshold value of 169 mg/cm3 was used for the separation of bone tissue from soft tissue. For 
the separation of trabecular and cortical bone tissues, an inner threshold of 480 mg/cm3 was applied 
at the distal bone sites and threshold of 710 mg/cm3 at the proximal measurement sites2. In all 
measurement analysis, iterative contour detection and filtration (contour mode 2 and peel mode 2) 
were used to define the total trabecular and cortical bone areas. The contour algorithm begins by 
searching for a voxel that represents the threshold defined by the operator, and the search continues 
until two neighboring voxels are found, and then the process continues all around the bone returning 
to the starting point. The trabecular and subcortical bone areas were separated with a filtration 
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algorithm that ignores isolated high attenuation voxels in the trabecular areas and in areas that are 
not continuous. 
The following bone traits were obtained: total bone mineral content (in mg), total and cortical bone 
areas (in mm2), trabecular and cortical bone densities (in mg/cm3). In addition, three bone strength 
indices were estimated. The conventional stress-strain index (in mm3) that represents the resistance 
of the bone against torsional load was calculated for both distal and proximal bone sites. 
Additionally for the distal sites, bone strength index (in g2/cm4) that represents the bone strength 
against compressive loading was calculated as a product of volumetric bone mineral density 
squared and total cross-sectional area3,4. For distal and proximal sites of radius and tibia, cortical 
strength index was calculated as the ratio of cortical bone area and total bone area. For statistical 
analyses, four composite indices of bone mass, density, area and strength were calculated from the 
trabecular and cortical bone area, mineral content and mineral density measured at radius and tibia 
at both distal and shaft sites. Additionally, the four indices were combined to one sum index. 
Measurements of the bone traits with ultrasound 
A quantitative ultrasound technique (Sahara Clinical Bone Sonometer, Hologic, Waltham, MA, 
USA) was used to measure speed of sound (m/s) and broadband ultrasound attenuation (dB/MHz) at 
the left heel. The speed of sound value depends on the structural elasticity of the trabecular bone, 
and is linearly dependent on bone mineral density5. The broadband ultrasound attenuation reflects 
some aspects of trabecular architecture and bone mineral density6. The Sahara device measures both 
speed of sound and broadband attenuation at the mid-calcaneus, and combines these indices to 
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estimate heel bone mineral density (in g/cm2) using the following equation (= 0.0025926*(speed of 
sound + broadband ultrasound attenuation) - 3.687). 
Quantitative ultrasound technique was used to measure ultrasound broadband attenuation (decibel per 
megahertz) and the speed of sound (m/s) at calcaneus, and the proportion of attenuation of the speed 
of sound was calculated to construct a quantitative ultrasound index (Supplementary Table 1). The 
speed of sound indicates the structural elasticity of the trabecular bone and it is linearly dependent on 
bone mineral density7. The broadband ultrasound attenuation indicates the frequency-dependent 
pattern of absorption reflecting the trabecular architecture and bone mineral density8. Bone mineral 
density T- scores were calculated as the difference from the sex-specific averages in the reference 
population aged 20–40 years. 
To evaluate the precision of the ultrasound and computed tomography methods, repeated scans of 
volunteers were obtained in each centre before starting and after completing the measurements. In a 
group of 39 women and men (aged 24 to 64), either radius or tibia or both extremities and calcaneus 
were measured twice with repositioning and for pQCT scans also including the assessment of bone 
length. The in vivo coefficients of variation (CV%) for the radius were 2.5% for TotA at distal site 
and 3.9% at the shaft site, 4.4% for CorA at distal site and 1.1% at shaft site, 1.6% for the TraD at 
distal site, 3.2% for the CorD at the distal site and 0.5% at the shaft site. The CV%s for the tibial 
traits were 1.3%, 1.2%, 2.6%, 1.2%, 0.5%, 1.2% and 0.6%, respectively. The long-term 
performance of the pQCT scanner was assessed by daily phantom measurements, which showed no 
significant drift in the density levels during the study year. Each pQCT scan was individually 
analysed by the same researcher according to the analysis protocol. Another researcher repeated the 
measurement analyses for randomly selected scans (157; 8% of the total number of subjects; 76 
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females and 81males), and no significant differences were found in the repeated scan analyses. In 
the repeated QUS measurements of the volunteers, the in vivo CV% was 0.3% for SOS and 4.8% 
for BUA. The long-term performance of the SAHARA device was assessed by daily phantom 
measurements that showed no significant changes in the measurement levels during the study year. 
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Supplementary results 
Supplementary Table 1: Baseline characteristics 
Supplementary Table 2: Bone metrics characteristics 
Supplementary Table 3: Sensitivity analysis results for different cotinine level cut-off points 
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Supplementary Table 1. Baseline characteristics of the 1422 participants of the Cardiovascular Risk in Young Finns Study stratified by exposure to 
parental smoking*.  
Non-exposed 
N=410 
Exposed 
N=1012 
One parent smoking regularly 
N=703 
Both parents smoking 
regularly 
N=309 
Mean (SD) / % Range Mean (SD) / % Range Mean (SD) / % Range 
Age (years) 10.1 (5.1) 3-18 10.5 (4.8) 3-18 9.1 (4.6) 3-18 
Males (%) 39 43 41 
Birth weight (g) 3547 (499) 1870-5250 3495 (577) 1100-5450 3472 (532) 1300-4980 
Weight (kg) 36.4 (17.3) 11.2-91.8 38.5 (17.3) 12.1-87.4 33.5 (16.5) 11.3-91.2 
Height (cm) 139.5 (26.0) 86.8-189.2 142.3 (25.1) 90.4-192.5 134.5 (25.0) 89-190.1 
Body mass index (kg/m2) 17.4 (2.8) 11.9-29.3 17.8 (2.9) 9.2-28.7 17.3 (2.8) 12.8-30.4 
Serum 25-OH-D (nmol/l) 54.1 (15.7) 12-122 51.0 (15.3) 17-114 54.0 (15.4) 18-96 
Parental school years 11.2 (3.9) 1-28 10.6 (3.6) 1-25 11.3 (3.3) 4-22 
* Those individuals who had reported own active smoking at baseline when aged 12-18 years were excluded from the analyses.
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Supplementary Table 2. Bone metrics measured by peripheral quantitative computed 
tomography and the bone trait indices calculated thereof, and the variables acquired by 
quantitative ultrasound at the age of 31-46 years.   
Peripheral quantitative computed tomography measurements (N=1422) 
Bone quality 
metrics 
Bone Mean (SD) Range 
Bone 
trait 
indices 
Calculation of the 
bone trait indices 
Mean 
(SD) 
Distal total 
mineral content 
(mg) 
Radius 244 (64) 129-530 
Bone 
mass 
(mg) 
Distal total mineral 
content + shaft 
cortical bone 
mineral content; 
from radius and 
tibia 
1698 
(324) 
Tibia 602 (127) 344-1102 
Shaft cortical 
bone mineral 
content (mg) 
Radius 213 (44) 132-359 
Tibia 645 (110) 400-1084 
Distal total area 
(mm2) 
Radius 359 (75) 192-660 
Bone 
area 
(mm2) 
Distal total area + 
shaft total area; 
from radius and 
tibia 
1739 
(290) 
Tibia 891 (150) 550-1522 
Shaft total area 
(mm2) 
Radius 113 (28) 53-224 
Tibia 382 (66) 223-682 
Shaft cortical 
density 
(mg/cm3) 
Radius 1198 (26) 1073-1261 
Bone 
mean 
density 
(mg/dm3) 
(Shaft cortical 
density from radius 
and tibia) / 2) + 
(Trabecular density 
from radius and 
tibia) / 2) 
706 (17) 
Tibia 1159 (23) 1064-1220 
Trabecular 
density 
(mg/cm3) 
Radius 225 (37) 124-369 
Tibia 241 (34) 153-361 
Radius -0.01 (1.001) -1.76-4.46 
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Bone strength 
index, 
standardized 
Tibia 0.01(1.007) -1.85-4.93 
Bone 
strain (z-
score) 
Bone strength 
index +  
stress strain index; 
from radius and 
tibia 
-0.08 
(3.55) Stress strain 
index, 
standardized 
Radius -0.02 (0.99) -1.76-4.68 
Tibia -0.01 (1.00) -2.28-4.51 
Sum index, 
standardized 
Sum 
index (z-
score) 
Combined z-score 
of bone mass, area, 
density and strain 
-0.02 
(3.22) 
Quantitative ultrasound measurements (N=1210) 
Bone measure Bone Mean (SD) Range 
Ultrasound broadband attenuation 
(decibel/megahertz) 
Calcaneus 
81 (16) 6-155 
Speed of sound (m/s) 1560 (29) 1494-1693 
Estimated bone mineral density T-
score 
-0.15 (1.02) -2.8-4.7 
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Supplementary Table 3. Sensitivity analysis on the independent effects of passive smoking in childhood (age of 3-18 years) on bone quality 
indices in adulthood (age 31-46 years) in 1136 participants of the Cardiovascular Risk in Young Finns Study. Analyses were performed excluding 
those who had reported own smoking at baseline when aged 12-18 years. 
No. exposed/ Sum index Bone mass Bone density Bone area Bone strain 
Cotinine cut-offs non-exposed β±SE P β±SE P β±SE P β±SE P β±SE P 
>0 and <20 ng/L 268/868 -0.36 0.010 -28.92 0.021 -2.47 0.039 -10.23 0.44 -0.32 0.021 
>1.0 and <20 ng/L 214/922 -0.38 0.115 -33.73 0.013 -2.04 0.11 -16.60 0.25 -0.36 0.017 
>1.5and <20 ng/L 174/962 -0.37 0.022 -33.82 0.022 -1.83 0.189 -19.78 0.21 -0.33 0.04 
>2.0 and <20 ng/L 136/1000 -0.34 0.06 -31.72 0.05 -1.81 0.24 -13.84 0.43 -0.33 0.07 
>2.5 and <20 ng/L 105/1031 -0.56 0.004 -48.08 0.009 -3.73 0.03 -20.44 0.30 -0.53 0.008 
>3.5 and <20 ng/L 66/1070 -0.65 0.01 -45.73 0.05 -5.99 0.005 -7.31 0.76 -0.46 0.06 
>4.0 and <20 ng/L 56/1080 -0.73 0.008 -55.67 0.02 -6.19 0.008 -9.05 0.73 -0.57 0.03 
Models adjusted for age, sex, body mass index, parental education, vitamin D concentration and physical activity level.
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